Adult stem cells, such as human mesenchymal stem cells (hMSCs), show limited proliferative capacity and, after long-term culture, lose their differentiation capacity and are therefore not an optimal cell source for tissue engineering. Human embryonic stem cells (hESCs) constitute an important new resource in this field, but one major drawback is the risk of tumor formation in the recipients. One alternative is to use progenitor cells derived from hESCs that are more lineage restricted but do not form teratomas. We have recently derived a cell line from hESCs denoted hESC-derived mesodermal progenitors (hES-MPs), and here, using genome-wide microarray analysis, we report that the process of hES-MPs derivation results in a significantly altered expression of hESC characteristic genes to an expression level highly similar to that of hMSCs. However, hES-MPs displayed a significantly higher proliferative capacity and longer telomeres. The hES-MPs also displayed lower expression of HLA class II proteins before and after interferon-g treatment, indicating that these cells may somewhat be immunoprivileged and potentially used for HLA-incompatible transplantation. The hES-MPs are thus an appealing alternative to hMSCs in tissue engineering applications and stem-cell-based therapies for mesodermal tissues.
Introduction
T issue engineering is an emerging field of research aimed at regenerating functional tissues by combining cells with a supporting substrate. Stem cells are suitable cell types for this application owing to their expansion potential and ability to differentiate into a variety of tissues. Several different embryonic stem cell lines and adult stem cell sources have been used for this purpose, [1] [2] [3] [4] underlining that some specific cell types may give better results in some particular applications. Among them, human embryonic stem cells (hESCs) constitute an important new resource in tissue engineering, mainly because of an extensive differentiation capacity and high proliferative potential. In fact, many adult organ-specific cells and stem cells show a limited proliferative capacity and, after long-term in vitro culture, lose their functional quality. 5 On the other hand, a major disadvantage with hESCs is the risk of tumor formation in the recipients. 6 hESC-derived mesodermal progenitors (hESMPs) are derived from hESCs but are more lineage restricted and do not form teratomas in vivo. Similarly to hESCs, hESMPs have a capacity for self-renewal and differentiation, but these properties are more limited. 7 The derivation of hES-MPs from hESCs using different protocols has been described earlier. [8] [9] [10] [11] [12] None of these protocols address the important aspects of xeno-free derivation, robustness, and safety for the use in tissue engineering and cell therapies. We therefore recently developed an optimized protocol resulting in simple and reproducible derivation of hES-MPs from undifferentiated hESCs. 7 Multiple hES-MP cell lines have been derived and characterized using this protocol, including a xeno-free hES-MP cell line from xenofree parental hESCs, and their differentiation capacity toward tissues of the mesodermal lineage, including the osteogenic, chondrogenic, and adipogenic lineages has been demonstrated. 7 The mesodermal commitment of the hESMPs suggests that these cells are closely related to stem cells of the mesenchymal lineage and raises the urge for further characterization. Human mesenchymal stem cells (hMSCs) represent a source of pluripotent cells that are already in various phases of clinical application. However, the use of hMSCs in tissue engineering has been hampered largely due to their low proliferation, finite life span, and gradual loss of their stem cell properties during ex vivo expansion. 5 Today, the transcriptional changes occurring during hES-MP derivation have not been studied and it is not either known how closely the hES-MPs resemble hMSCs. There is further a lack of knowledge concerning the immunological properties of these hES-MPs as well as their regulation of senescence and proliferative capacity. These questions are a prerequisite to investigate in order to replace hMSCs with hESC-derived progenitor cells in future tissue engineering applications, which prompted us to comprehensively study these issues.
Materials and Methods

Cell types and culture conditions
The undifferentiated hESC lines used in this study were the SA167, SA002.5, and SA461, derived and characterized at Cellartis AB, Gothenburg, Sweden. Detailed protocols are available at Cellartis (www.cellartis.com). The hES-MP cell lines were derived from the three undifferentiated hESC lines described above, as previously reported. 7 hMSCs were isolated from bone marrow aspirates from the iliac crest of patients undergoing spinal fusion (age range 13-20 years) and expanded as described previously. 13 The cells were harvested for RNA isolation in passage 3 when the cells reached 80% confluence. The donation of bone marrow was approved by the ethics committee at the Medical Faculty at Gothenburg University (Dnr. 532-04).
Flow cytometry analysis
Flow cytometry analysis was used to confirm isolation and enrichment of hMSCs, verify microarray results, and examine expression of immunological markers. To verify enrichment of hMSCs, cells were stained with CD34-PerCP, CD45-FITC, CD105-FITC, and CD166-PE (all from Ancell). To verify the microarray results, hMSCs, hES-MPs, and hESCs were stained with CD44-FITC (BD Biosciences), CD58-PE (BD Biosciences), CD47-FITC (BD Biosciences), and CD166-PE. Expression of immunological markers was studied in both hMSCs and hES-MPs at low and high passage (defined as 5 and 50 population doublings [PDs] , respectively) as well as before and after a 5-day treatment with interferon-g (IFN-g) (100 U=mL; R&D Systems Europe). The cells were then stained with HLA-ABC-FITC, HLA-DR-FITC, CD80-FITC (all from BD Biosciences), and CD86-PerCP-Cy5 (Ancell). All samples were analyzed using the FACS Aria flow cytometer (Becton Dickinson) using FACS Diva software (Becton Dickinson).
RNA isolation
Total RNA was extracted using the RNeasy Ò Minikit (Qiagen GmbH) according to manufacturer's instructions. DNAse treatment was performed to eliminate any contamination from genomic DNA according to Qiagen RNase Free DNase Set (Qiagen GmbH) protocol.
Microarray analysis
RNA from hESCs, hES-MPs, and hMSCs was subjected to gene expression analysis using the oligonucleotide microarray HG-U133plus2.0 (Affymetrix) according to manufacturer's recommendations. Raw expression data were normalized and subsequently analyzed with GeneChip Operating Software 1.4 (GCOS; Affymetrix). Comparative and statistical analyses were performed with the BIORETIS Web tool (www.bioretisanalysis.de). Genes were selected for further analysis only if (1) the absolute call for the gene was present for at least one of the three cell types, (2) three out of three comparisons had to be considered increased or decreased according to Affymetrix algorithm, and (3) the average fold change (FC) should be at least twofold. Using these qualitative and quantitative filtering criteria, we performed two comparative analyses, one between hES-MPs and hESCs and the other between hES-MPs and hMSCs. Functional classification into five different categories-transcription factors, extracellular matrix components, growth factors, membrane receptors, and cell adhesion molecules-was performed using annotations from the Gene Ontology Annotation Database.
14 Further, expression of 48 genes known to be overexpressed in hESCs compared with differentiated cell types, 40 genes specifically expressed in hESCs, and 30 selected genes underexpressed in hESCs compared with differentiated cell types was investigated. 15 For these genes, the mean expression level from different probe sets of each gene was calculated and reported in Table 1A-C. The significance level was determined applying the Welch's ttest on log2-transformed signal values. Hierarchical cluster analysis was performed using log2-transformed signals of all the replicates using Genesis 1.7.3 software. 16 To explore the similarity in global gene expression pattern across investigated samples, the correlation was calculated using standard function in R statistical software. Spearman was used as correlation coefficient, and genes with missing values were excluded from the calculation. The interpretation of this analysis is as follows: 1 means perfect correlation, À1 means negative correlation, and 0 means no correlation.
The percentage of genes with an FC 3 between pairs of samples was calculated for all three comparisons (hES-MPs vs. hMSCs, hES-MPs vs. hESCs, and hMSCs vs. hESCs). This FC-threshold was defined based on the results from comparisons of the biological replicates. To define the background variation, the FCs between pair-wise replicates were calculated, and the results showed that 90% of all the genes have an FC 3 between any two replicates of a sample.
To observe the similarity in global gene expression across the investigated cell samples, scatter plots were generated between average signals of pairs of samples using standard function in R.
Analysis of protein interaction networks
To investigate possible interactions among proteins from differentially expressed genes (defined by having an FC of at least 10) between hES-MPs and hESCs or hES-MPs and hMSCs and to identify hub proteins, the search tool STRING (http:==string.embl.de) was used to mine for recurring instances of neighboring genes. A gene of interest was classified as a hub if it had at least five interactions with other genes. 14 
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Quantitative real time-polymerase chain reaction
Microarray results were verified using real-time polymerase chain reaction (PCR), flow cytometry, and immunohistochemistry. For real-time PCR, reverse transcription was carried out using iScript cDNA Synthesis Kit (Bio-Rad) according to manufacturer's instructions. Design of primers for TDGF, TGF-b2R, RUNX2, COL1A1, LHX8, and BMP2R was performed using the Primer3 Web-based software. Primer sequences and detailed protocols are available at TATAA Biocenter AB, Gö teborg, Sweden (www.tataa.com). Statistical analysis for real-time PCR data was performed using the Mann-Whitney test. Differences were accepted to be statistically significant at p 0.05 (*).
Immunohistochemistry
Monoclonal antibodies against the pluripotency markers OCT4 and NANOG were used to immunohistochemically verify the microarray results. The procedure used for the analysis has previously been described. 17 
Proliferative capacity
To compare the expansion ability of hMSCs and hES-MPs, cells were expanded as described above and passaged when one of them reached 80% confluence. At each passage, cells were counted in a hemocytometer and the number of cell doublings was calculated.
Telomerase activity
Telomerase activity was evaluated using the TeloTAGGG Telomerase PCR ELISA PLUS kit (Roche Diagnostics Scandinavia AB). Both hMSCs and hES-MPs at low and high passage were analyzed according to manufacturer's recommendations. The PCR was performed using a Thermal Cycler 2720 (Applied Biosystems), and the absorbance was read at 450 nm using the iEMS reader MF (Labsystems) microtiter plate reader and Ascent software. All samples were analyzed in triplicates, and heat-treated samples were used as negative control.
Telomere length
To investigate the length of the telomeres, DNA was isolated with Qiagen DNeasy Blood & Tissue Kit (Qiagen AB) according to the manufacturer's protocol from both hMSCs Genes significantly regulated are in boldface.
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and hES-MPs at low and high passage. After isolation of DNA, the length of the telomeres was measured using the TeloTAGGG Telomere Length Assay kit (Roche Diagnostics Scandinavia AB) according to the protocol provided by the manufacturer.
Results
Flow cytometry analysis of hMSCs
Flow cytometry analysis was used to evaluate the enrichment of a homogenous population of hMSCs, demonstrating that 96% AE 2% of the cells were CD166 þ =CD45 À and 94% AE 1% of the cells were CD105þ=CD34À.
Cell morphology
While hESCs (Fig. 1A) exhibited their typical morphology and characteristic growth in colonies, the hES-MPs (Fig. 1B ) displayed a fibroblast-like morphology characteristic of hMSCs (Fig. 1C) .
Global gene expression comparison
Scatter plot analysis of the microarray data for each pairwise comparison showed that hES-MPs and hMSCs display a more narrow spatial distribution of gene expression, with 90% of the genes displaying an FC 3 ( Fig. 2A, D) . Results from the other two comparisons (hESCs vs. hES-MPs and hESCs vs. hMSCs) showed larger transcriptional differences with 25% or more of the genes with an FC !3 ( Fig. 2B-D) . The Spearman correlation coefficients demonstrated a higher correlation between hES-MPs and hMSCs (0.92) than between hESCs vs. hES-MPs (0.83) and hESCs vs. hMSCs (0.79) (Fig. 2D ). Hierarchial clustering of 447 genes with an FC !20 resulted in three main groups-hESCs, hES-MPs, and hMSCs ( Fig. 2E ). This analysis further demonstrates that the hES-MPs and the hMSCs display a more similar expression pattern than hES-MP compared with hESCs.
In Table 1A , the expression levels of 40 genes known to be specifically expressed in hESCs is shown. Out of these genes, 27 genes were significantly downregulated during hES-MP derivation and most of the genes (32 out of 40) displayed a transcription level similar to hMSCs. Among these genes, several genes involved in the maintenance of pluripotency (POU5F1, NANOG, ZIC3, TDGF1, and LIN28) significantly decreased in expression at least 50 times during hES-MP derivation; with the exception of NANOG, no significant differences in expression of these genes were detected between hES-MPs and hMSCs. None of the markers for hESCs increased in expression during hES-MP derivation. Three genes (BRRN1, FLJ20105, and HELLS) displayed an at least Genes significantly regulated are in boldface.
10-fold higher expression in hES-MPs compared with hMSCs, whereas MCM10, CDC25A, and ORC1L showed a 9.7-fold, 6.1-fold, and 4.6-fold higher expression in hES-MPs compared with hMSCs. Analyzing expression of 48 genes known to be overexpressed in hESCs compared with differentiated cell types demonstrated that 39 genes decreased in transcription during hES-MP formation (Table 1B) . Within this group of genes, some additional genes of importance for pluripotency were detected as significantly downregulated during hES-MP derivation, including LEFTY1 and SOX2. None of the 48 genes known to be overexpressed in hESCs compared with differentiated cell types displayed higher expression in hESMPs compared with hESCs. Genes differentially expressed between hES-MPs and hMSCs include MCM5, which had 9.2-fold higher expression in hES-MPs compared with hMSCs, and PLA2G16, displaying a higher expression in hMSCs.
Of the 30 selected genes known to be underexpressed in hESCs compared with differentiated cell types, 15 genes were induced during hES-MP derivation (Table 1C) . Some of these genes include genes encoding mesodermal extracellular matrix components (COL1A1, COL1A2, COL2A1, COL3A1, COL5A1, COL5A2, COL11A1, and COL6A3) ( Table  1C ). The majority of these genes were induced to the same level as seen in hMSCs. On the other hand, genes encoding markers for ectodemal tissues, such as keratins (KRT18, KRT19, KRT7, and KRT8) were not induced during the process of hES-MP formation.
In Table 2 (A, B), the 15 most up-and down-regulated genes per each of the 5 categories described above are listed, if existing. Several genes encoding transcription factors displayed a decreased transcription during hES-MP derivation (SIX1, PPRX1, NR2F2, BNC1, RUNX2, and BCOR). The hMSCs displayed the highest expression level of the HOX genes (HOXA9, HOXA10, HOXC6 , and HOXC10), their downstream mediator EMX2 and IRX3, as well as FOS genes (FOS and FOSB). Studying genes encoding extracellular matrix components induced during hES-MP derivation, we added the following genes to the results described above: COL1A2, COL6A2, COL6A, BGN, MFAP5, FN1, and FBN1. Several genes encoding matrix proteins were thus induced during hES-MP formation; in fact, the only gene in this category that was found to have higher expression in hESCs than in hES-MPs and hMSCs was LAMA1.
For the membrane receptor category, essential receptors for mesodermal differentiation, such as TGFRB2 and BMPR2, are shown to be expressed to a greater extent in hES-MPs and hMSCs compared with hESCs. Finally, genes encoding cell adhesion molecules, including the hMSCs markers CD44, CD58, CD47, and CD166 (ALCAM), were significantly induced during hES-MP derivation to a level similar to hMSCs.
In total, 9 hubs were identified among the genes induced by hES-MP derivation (PLAU, THBS1, FN1, COL1A1, COL1A2, MFS2, CD44, CDKN2A, and CAV1) (Fig. 3A) . Only one hub, EWSR1, was identified among the genes repressed during this process (Fig. 3B ). Hub genes with higher expression in hES-MPs compared with hMSCs include several genes composing the spindle assembly checkpoint (CDC20, AURKA, AURKB, BUB1B, NDC20, MAD2, ERCC6L, NUF2, CENPA, AP14, SPC24, D40, SPC25, CENPM, MLF1IP, ZWINT, CENPF, CDCA8, NEK2, and 
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CCNB1) (Fig. 3C) . Only one hub gene, JUN, was identified among the genes with higher expression in hMSCs than hES-MPs (Fig. 3D ).
Real-time PCR
Microarray results for TDGF, TGF-b2R, RUNX2, COL1A1, LHX8, and BMP2R were verified using real-time PCR, which corroborated the microarray results in all cases except for BMP2R, in which no significant differences could be detected between the three different cell types studied (Fig.  4A-F) .
Flow cytometry
The flow cytometry analysis confirmed the microarray results for adhesion proteins characteristic for hMSCs (CD44, CD58, CD166, and CD47), demonstrating that the undifferentiated hESCs displayed significantly lower expression of these four markers compared with the hMSCs and hES-MPs, which showed a comparable expression for all of the markers studied ( Fig. 4G-J) .
Immunohistochemistry
Immunohistochemistry demonstrated that only hESCs were positively stained for OCT4 and NANOG as shown in Figure 4 (K, N) , whereas hES-MP cells (L, O) and hMSCs (M, P) were negative for both markers.
Proliferation ability
Throughout the proliferative assay, the hES-MPs displayed a significantly higher number of cell doublings per time period compared with the hMSCs (Fig. 5A) . Around passages 8-10, an initial decline in the proliferative potential of hMSCs was detected. This was followed by a more or less ceased proliferation after passage 20. The hESMPs, on the other hand, retained their high proliferative capacity for the whole duration of the test (up to passage 30).
Telomerase activity and telomere length
Both hES-MPs and hMSCs at PD 5 and 50 showed a similar level of telomerase activity (Fig. 5I) . In contrast, the telomeric repeat fragments were longer for hES-MPs compared with hMSCs at both passages investigated (Fig. 5H) .
HLA expression
Flow cytometry analysis for immunological markers demonstrated that both hMSCs and hES-MPs were found to be negative for CD80 (Fig. 6A, I ) and CD86 (Fig. 6B, J) . Expression of these two markers was further not affected by IFN-g treatment in either hMSCs (Fig. 6E, F) or hES-MPs (Fig. 6M, N) . On the other hand, all hMSCs were positive for HLA-ABC (Fig. 6C ) and about half of the hMSC population was also positive for HLA-DR (Fig. 6D) . Expression of these two markers further increased after IFN-g treatment (Fig. 6G, H) . In contrast, the hES-MPs displayed somewhat lower expression of HLA-ABC compared with the hMSCs (Fig. 6K) and were negative for HLA-DR (Fig. 6L) . Expression of HLA-ABC after IFN-g treatment of hES-MPs (Fig.  6O ) was similar to that of IFN-g-treated hMSCs. A small population of hES-MPs became positive for HLA-DR after IFN-g treatment (Fig. 6P) , but the expression level is significantly lower compared with that of the hMSCs. The same results were detected for cells in high passage (data not shown). 
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Discussion
The main questions addressed in this study were how the transcriptome is affected by the process of hES-MP derivation, and how distinct or equivalent cell types the hESCs and the hESC-derived hES-MPs are. Our results from hierarchical cluster analysis, scatter plot analysis, and Spearman correlation analysis all demonstrated that our straightforward protocol for derivation of hES-MPs results in a cell line highly similar to hMSCs, which is in accordance with earlier results from our laboratory. 7 These transcriptional alterations occurring during hES-MP derivation result in a significantly decreased transcription of genes known to be specifically expressed in hESCs. For instance, the OCT family of genes (POU5F1, POU5F1P3, and POU5F1P4) as well as NANOG are essential transcription factors involved in the maintenance of pluripotency with exclusive expression in ES cells. [18] [19] [20] [21] In accordance, SOX2, which has been found to form a complex with OCT4 and bind to the NANOG promoter in hESCs, 22 was shown to be highly expressed in hESCs and down-regulated during hES-MP derivation to a level similar that in hMSCs. A similar expression pattern was observed for other genes important for pluripotency, including TDGF1, LIN28, GDF3, ALPL, GAL, DPPA4, GABRB3, and ZIC3. 15, [23] [24] [25] [26] [27] [28] Repression of these genes detected during hES-MP derivation thus provides the molecular evidence for the lineage commitment detected in hES-MPs compared with hESCs. 7 Pluripotency is strongly associated with teratoma formation, and one of the most well-known genes to induce these processes is TDGF1. 29, 30 The same expression pattern was detected for EPHA1, which is overexpressed in many tumors, and DNMT3B, which is known to inhibit tumor suppressor genes. 31, 32 Another important gene for tumor development is p53, whose inactivation is a common feature in many tumors and whose transcription is induced by binding of NR2F2 to the p53 promoter. 33 Significantly increased expression of NRF2F during hES-MP formation, as well as altered expression of the p53-associated genes LTBP2 and TFAP2A, is thus yet another way for the hES-MP cells to decrease their tumorigenicity. 34, 35 Identified hub genes induced by hES-MP derivation include THBS1, known to inhibit angiogenesis, as well as the tumor suppressor CDKN2A ( p16) and CAV1. 36, 37 The tumor-associated gene EWSR1 was identified as the only hub for genes with a reduced expression pattern during the process of hES-MP derivation. This study thus provides the molecular clues for the lack of teratoma formation detected in the hES-MPs, which is a prerequisite for possible future clinical applications. With regard to genes associated with proliferation, a panel of such genes (HELLS, CDC25A, MCM5, FGF5, BUB1, and ORC1L) was significantly downregulated during hES-MP derivation, but hES-MPs still had significantly higher expression of these genes compared with hMSCs. HELLS is ubiquitously expressed in rapidly dividing cells, 38, 39 and targeted disruption of HELLS leads to increased replicative senescence along with altered gene expression pattern, particularly the senescence-related genes such as CDKN2A and BMI1. 40 Moreover, CDKN2A is one of the hub genes identified in the process of hES-MP derivation as discussed above. The hES-MPs further displayed significantly higher expression of MCM10, MCM5, and ORC1L required for DNA replication, the mitogen FGF5, and CDC25A known to accelerate S-phase entry. [41] [42] [43] [44] Another pathway inducing proliferation activated during hES-MP derivation was signaling via EGF, and increased expression of HBEGF, the receptor EGFR, and its ligand EREG was detected. 45 Other signaling pathways seem to regulate hMSC proliferation, including the FOS family of transcription factors inducing quiescent cells to reenter the cell cycle. 46 This protein together with JUN, which was identified as a hub gene with increased expression in hMSCs, forms the AP-1 complex. 47 The expression pattern of genes in hES-MPs resulting in increased proliferative potential is in line with the high proliferative capacity of these cells (shorter PD time and retained proliferative potential over extended time) compared with hMSCs demonstrated in this study. Decreased proliferative potential of hMSCs during long-term in vitro culture has earlier been demonstrated and has to some extent been explained by the decreasing telomere length. 48 The high proliferative potential of the hES-MPs is further in accordance with the presence of longer telomeres compared with the hMSCs, while no differences in telomerase activity was detected. The differences in telomere length observed between hES-MPs and hMSCs may be associated with the intrinsic different source of the two cell types. Isolation from adult donors implies that hMSCs have undergone a higher number of cell divisions, resulting in the shortening of their telomeric sequences. hMSCs displayed increased telomeric length at PD50, suggesting that other mechanisms, known as alternative lengthening of telomeres, which are recognized to be involved in oncogenic transformation, 49 may become activated in hMSCs after protracted expansion. From a different standpoint, these data can be interpreted as results of natural selections, where cells carrying an advantageous ability to keep their telomeric sequences take over the culture and eventually represent the only population of cells able to proliferate for long time. The higher proliferative potential of the hES-MPs provides these cells with a great advantage over hMSCs for bulk production of cells for therapy and tissue engineering applications.
During each cell division cycle, the newly duplicated chromosomes must be distributed evenly into the new cells so that each cell receives exactly one copy of each chromosome. Errors in this process result in aneuploidy that is manifested in genetic disorders and tumors. Accurate sister chromatid segregation relies on the attachment and alignment of chromosomes to the mitotic spindle. This process is controlled by the spindle assembly checkpoint, which restrains cells from entering anaphase until all replicated chromatids have formed proper attachments to a functional bipolar spindle. Several genes encoding proteins constituting this complex, such as CDC20, MAD2, BUB1B, NDC80, NUF2, CENPA, ERCC6L, SPC24, MLF1IP, AURKB, D40, SPC25, CENPM, ZWINT, and CDCA8, were identified as hub genes with significantly increased expression in hES-MPs compared with hMSCs (for review, see Bharadwaj and Yu 50 ). Inactivation of certain checkpoint genes results in early embryonic lethality, high levels of chromosome mis-segregation, and apoptosis. 51 The identification of these hub genes overexpressed in hES-MPs demonstrates a strong control function of mitosis important to reduce the risk of tumor formation.
Analyzing expression of 48 genes overexpressed in hESCs compared with differentiated cells demonstrated that hESMPs derivation results in a more differentiated cellular phenotype consistent with its lineage commitment discussed above and increased expression of markers downregulated in hESCs compared with differentiated cell types. hES-MP derivation did not result in altered expression of genes encoding keratins (KRT18, KRT19, KRT7, and KRT8) demonstrating lack of differentiation into the ectodermal lineage. Decreased expression of several claudins (CLDN3, CLDN6, CLDN8, CLDN10, and CYP26A1) known to be important for retinoic acid metabolism during endodermal differentiation and the early neural marker CRMP1 demonstrates lack of differentiation into the endodermal lineage during hES-MP derivation. 52, 53 The above results are in accordance with the findings previously observed, where hES-MPs were found to be negative for markers typical of the ectodermal and endodermal lineage. 7 In contrast, a panel of genes encoding collagen and other genes characteristic for mesodermal tissues (COL1A1, COL1A2, COL3A1, COL5A1, COL11A1, COL6A1, COL6A2, DDR2, BGN, FN1, FBN1, and MFAP5) and proteins important for cell-to-cell contact or attaching cells to the extracellular matrix (CD44, CD58, CD47, and CD166) were induced by hES-MP derivation to a level similar that in hMSCs. 54 Other signs of lineage commitment into the mesodermal lineage include increased expression of genes encoding membrane receptors responsive to growth factors inducing mesodermal differentiation (TGFBR2 and BMPR2), 55 and overexpression of RUNX2 56 and TFAP2A, 57 known to be expressed during osteogenic differentiation. This differentiation into the mesodermal lineage detected might be due to significantly decreased expression of LEFTY1 detected during hES-MP derivation. Lefty 1 is known to block Nodal signaling by binding Nodal and its coreceptors such as TDGF1. This binding prevents the assembly of an active Nodal=Activin receptor complex, resulting in inhibited mesodermal development. 58, 59 The only gene coding for an extracellular matrix component that displayed higher expression in hES cells than in hES-MPs was LAMA1. This gene is involved in embryonic patterning and is one of the few essential extracellular matrix proteins in early embryogenesis. 60 It is further significantly downregulated upon development and ES cell differentiation, which is consistent with its decreased expression during hES-MP formation. 61 Induction of these mesodermal markers by hES-MP derivation to the same extent as seen in hMSCs demonstrates the potential of the hES-MP cells in tissue engineering of mesodermal tissues. 62 These data further corroborate previous results demonstrating the in vitro and
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in vivo differentiation of hES-MPs into tissues of the mesodermal lineage. 7 The most overexpressed transcription factors detected in hMSCs compared with hES-MPs were HOXA9, HOXA10, and their downstream effector IRX3, whose expression pattern indicates a suppression of erythroid differentiation in hMSCs, reflecting the origin of these cells and the need for this system to maintain the cells undifferentiated. 63 On the other hand, the most highly upregulated transcription factor in hES-MPs compared with hMSCs was LHX8, which is essential for tissue patterning and differentiation during embryogenesis. 64 Other transcription factors upregulated in hES-MPs compared with hMSCs were SALL1, PAX3, MSX1, DLX1, DLX2, and LZTS1. SALL1 is known to play a function in limb cartilage morphogenesis, 65 while PAX3 promotes myogenic differentiation during vertebrate development. 66 High expression of DLX1, DLX2, and MSX1, supporting craniofacial development and osteogenesis, 67, 68 underscores the potential of hES-MPs for mesodermal tissue engineering.
Increased expression of the tumor suppressor gene LZTS1 in hES-MPs compared with hMSCs may represent an ideal characteristic for clinical applications of these cells. [69] [70] [71] Most of the extracellular matrix components retrieved when comparing hES-MPs and hMSCs displayed a significant upregulation in hMSCs, indicating a more adult phenotype of the hMSCs. In relation to this assumption, the majority of these genes were further downregulated in hESCs compared with hES-MPs, suggesting that hES-MPs may represent an intermediate differentiation state between embryonic and adult stem cells.
The immunological profile of the hES-MPs is highly important for their possible future use in tissue engineering and cell therapy. hES-MPs displayed somewhat lower expression of HLA-ABC compared with hMSCs and significantly lower expression of HLA-DR. Transplantation of an allograft elicits a cascade of host responses in vivo, including secretion of IFN-g, one of the most potent inflammatory cytokines, which further is known to stimulate expression of HLA molecules. 72 The significantly lower induction of HLA-DR in hESMPs, as opposed to the response in hMSCs, demonstrates that hES-MPs are more immuno-privileged than the hMSCs, and therefore represent a suitable alternative for in vivo applications.
Conclusion
As far as we know, this is the first comprehensive study reporting the profound transcriptional changes occurring during hES-MP derivation, resulting in a gene expression profile highly similar to that of hMSCs. These results, in combination with the immunological properties of the hESMPs reported in this study and the significantly increased proliferative potential of these cells compared with hMSCs, demonstrate that hES-MPs represent a valuable alternative to hMSCs in tissue engineering applications. This data set will also be a valuable resource to the research community to distinguish hES-MPs from hESCs.
